Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Denali Therapeutics
Research
Researchers receive $6.9M NIA grant for tau-targeting drug
The drug helps stabilize the connections between the Alzheimer’s-associated protein tau and microtubules, key structural components of nerve cells.
Darren Incorvaia
Aug 21, 2024 1:02pm
Denali reports new method to get ASOs across blood-brain barrier
Aug 14, 2024 2:00pm
Biogen walks away from Denali Alzheimer's collab
Aug 1, 2024 10:27am
FDA picks Denali, Neurogene and more for rare disease program
Jun 4, 2024 2:51pm
Amid pivot, Denali Therapeutics sends staff packing
Feb 26, 2024 12:22pm
Sanofi stumbles in HIMALAYA trial, chalking up phase 2 ALS fail
Feb 20, 2024 4:40am